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ABSTRACT
Analysis of 247 faecal enterococcal isolates from
99 healthy Portuguese individuals during 2001
revealed the presence of enterococci resistant to
vancomycin (5%) and highly resistant to strepto-
mycin (52%), kanamycin (40%) or gentamicin
(11%). Most isolates were also resistant to tetra-
cycline, erythromycin, ciproﬂoxacin and quinu-
pristin–dalfopristin. The vanA (two Tn1546 types),
vanC1, erm(B), aac(6¢)-aph(2¢¢)-Ia, aph(3¢)-IIIa, vat(E)
and vat(D) genes were detected. Enterococcus
faecalis and Enterococcus faecium isolates with
high-level resistance to gentamicin were related
to Portuguese poultry isolates described previ-
ously. E. faecium isolates that were highly resist-
ant to vancomycin or gentamicin harboured
different housekeeping purK alleles associated
previously with different hosts.
Keywords Antimicrobial resistance, enterococci, fae-
cal ﬂora, Portugal, vancomycin resistance
Original Submission: 18 January 2006; Revised Sub-
mission: 24 April 2006; Accepted: 8 May 2006
Clin Microbiol Infect 2006; 12: 1131–1134
10.1111/j.1469-0691.2006.01542.x
Antibiotic-resistant enterococci (ABRE) have been
reported previously in nosocomial and commun-
ity settings following increased antibiotic usage in
humans and animals [1]. Despite measures adop-
ted in Europe, ABRE are still reported in healthy
humans (HH) and animals from areas with no
apparent selection pressure [2–4]. Recent studies
have demonstrated host-speciﬁcity for particular
enterococcal strains and genetic elements, which
are sometimes able to persist for long periods in
speciﬁc hosts [2,5,6]. However, similar strains and
genes encoding resistance to antibiotics used in
clinical practice have been observed in both
humans and animals [2,7]. The present study
analysed the presence of ABRE in faeces from
HH, as well as their clonal relationship with
strains from poultry in Portugal, a country with
high rates of ABRE in hospitals and the commu-
nity [8,9] (http://www.rivm.nl/earss).
Ninety-nine faecal swabs from HH (55 females,
44 males; age range 5–69 years, mean 30 years)
were collected in northern and central Portugal
(January–June 2001). Participants were questioned
concerning their contact with antibiotics, hospitals,
animal meat and live animals. Also included in the
study were 149 Portuguese poultry isolates (103
vancomycin-resistant enterococci and 46 with
high-level gentamicin resistance (HLGR) [8]).
Swabswere enriched in brain–heart infusion broth,
with and without vancomycin (6 mg ⁄L), to im-
prove the recovery of vancomycin-resistant en-
terococci. Enriched samples (100 lL) were plated
on Slanetz–Bartleymedia,with andwithout vanco-
mycin (6 mg ⁄L), gentamicin (125 mg ⁄L), strepto-
mycin (1000 mg ⁄L) or kanamycin (500 mg ⁄L).
Resistance to other antibiotics was considered to
be associated with the agents used in selection
plates in order to avoid over-estimation of results
by repeatedly counting isolates on different selec-
tion media. For each sample, one colony of each
morphological type and antibiotic susceptibility
proﬁle was studied. Susceptibility to 14 antibiotics
was determined by the agar dilutionmethod using
Enterococcus faecalis ATCC 29212 and Staphylococ-
cus aureus ATCC 29213 as control strains [10].
Species identiﬁcation, detection of genes confer-
ring resistance to glycopeptides, aminoglycosides,
macrolides, streptogramins, and characterisation
of Tn1546 structures were performed by PCR with
appropriate controls [11–15]. Conjugation experi-
ments with vancomycin-resistant enterococcal iso-
lates were performed by ﬁlter and ⁄ or brothmating
methods [16]. Enterococcus faecium and E. faecalis
isolates harbouring the vanA or aac(6¢)-aph(2¢¢)
genes were tested for clonal relationship by
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pulsed-ﬁeld gel electrophoresis [16]. Identiﬁcation
of purK alleles in vancomycin-resistant isolates and
selected isolates with HLGR was performed by
PCR ampliﬁcation and sequencing [5].
Enterococci (124 E. faecalis, 96 E. faecium, three
Enterococcus gallinarum and 24 unidentiﬁed En-
terococcus spp.) were recovered from 93% (92 ⁄ 99)
of HH samples. Most HH had not taken antibi-
otics (91 ⁄ 99; 92%) or had contact with hospitals
(94 ⁄ 99; 95%) during the 3-month or 12-month
periods, respectively, preceding sample collec-
tion. All except one individual had consumed
meat, i.e., poultry (94 ⁄ 99; 95%), pork (90 ⁄ 99; 90%)
or turkey (57 ⁄ 99; 57%), of more than one type in
most cases (90 ⁄ 99; 90%). Regular meat consump-
tion (more than ﬁve occasions per week) was
recorded for 79% (78 ⁄ 99) of individuals. Contact
with pets (mainly cats and dogs) or farm animals
was recorded in 56% (55 ⁄ 99) and 17% (97 ⁄ 99) of
HH, respectively.
A high percentage of samples contained en-
terococci with high-level streptomycin resistance
(52%) or high-level kanamycin resistance (40%)
and, to a lesser extent, HLGR (11%) or vancomy-
cin resistance (5%). Resistance to daptomycin or
to linezolid was not observed. Daptomycin break-
points were those recommended by the manufac-
turers (Chiron, Uxbridge, UK) (i.e., MIC <8 mg ⁄L
indicates susceptibility). Linezolid breakpoints
were those recommended by the European
Committee on Antimicrobial Susceptibility Test-
ing (EUCAST) (http://www.srga.org/eucastwt/
MICTAB/MICoxazolidones.htm). Co-resistance
to tetracycline, erythromycin, ciproﬂoxacin and
quinupristin–dalfopristin was found in most en-
terococci grown on selective plates. Six vancomy-
cin-resistant enterococcal isolates from ﬁve HH
were recovered, i.e., four vanA+ E. faecium and
two vanC1+ E. gallinarum. All HH vanA carriers
had consumed more than one type of meat, but
had not had contact with hospitals, antibiotics or
farm animals. The Tn1546 elements corresponded
to the PP-5 and D types described previously,
which have been associated with hospitals and
animal isolates, respectively [15–17].
Isolates with HLGR from 11 HH harboured
aac(6¢)-aph(2¢¢)-Ia (n = 5) or both aac(6¢)-aph(2¢¢)-Ia
and aph(3¢)-IIIa (n = 8). Isolates showing only
high-level kanamycin resistance (40 samples, 44
isolates) contained mostly aph(3¢)-IIIa (36 samples,
39 isolates). The erm(B) gene was detected in
both erythromycin-resistant and erythromycin-
non-resistant isolates (17 ⁄ 33 E. faecium from 22
samples). Interestingly, ﬁve erythromycin-resist-
ant isolates (MICs 8 to >32 mg ⁄L) did not harbour
erm(B), and 18% of isolates containing erm(B) did
not express it phenotypically (MICs 1–4 mg ⁄L).
The vat(E) and vat(D) genes were observed in one
E. faecium isolate each. The aph(2¢¢)-Ib, aph(2¢¢)-Ic,
aph(2¢¢)-Id, erm(A), erm(C) and mef(A) genes were
not detected. Transfer of vanA and co-transfer of
erm(B) was achieved in all cases by ﬁlter mating
(10)1)10)8 transconjugants per donor or recipient).
Three pulsed-ﬁeld gel electrophoresis types
were observed among four vanA-carrying E. fae-
cium isolates, and seven pulsed-ﬁeld gel electro-
phoresis types among eight isolates with HLGR
Fig. 1. Pulsed-ﬁeld gel electrophoresis types of isolates
with high-level gentamicin resistance from healthy
humans (HH) and poultry (P). Lanes 1 (P) and 2 (HH):
Enterococcus faecium clone 36. Lanes 3 (HH), 4 (P) and 5 (P):
Enterococcus faecalis clone 56.
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(two E. faecium and ﬁve E. faecalis). Two isolates
with HLGR (one E. faecalis and one E. faecium)
were related closely to poultry isolates described
previously (clones 36 and 56) (Fig. 1) [8]. Vanco-
mycin-resistant E. faecium harboured the purK-1
(one isolate representative of one clone) or purK-6
(two isolates representative of two clones) alleles,
while isolates with HLGR recovered from both
HH (one isolate) and poultry (one isolate) were
related to clone 36 [8] containing the purK-3 allele.
A high frequency of ABRE was detected among
HHs with no hospital and ⁄ or antibiotic exposure,
with the majority of isolates with vancomycin
resistance or high-level aminoglycoside resistance
also being resistant to erythromycin, tetracycline,
ciproﬂoxacin and quinupristin–dalfopristin, as
reported for enterococci of animal origin [8]. Most
of these antibiotic resistance genes are frequently
located in gene clusters associated with speciﬁc
plasmids, transposons or other widely distributed
transferable elements, which could explain the
presence of different multiresistance patterns,
even without selective enrichment [1,7]. The
susceptibility results of this study are summar-
ised in Table 1.
Resistance to several antibiotics has been
reported in a previous Portuguese study inclu-
ding HHs [18]. The lower resistance rates ob-
served for some agents in the previous study
might be related to the absence of an enrichment
method or antibiotic selection plates. This might
also explain the low rate of ampicillin resistance
revealed among the E. faecium population recov-
ered in this study. Although Portugal uses large
amounts of b-lactam agents [9], this observation is
supported by other studies with HH and animals,
suggesting that such strains are not disseminated
widely in the Portuguese community [8,18]. The
presence of strains with HLGR that are similar to
those described previously in poultry [8] indicates
Table 1. Reduced susceptibility to 12 antimicrobial agents among 247 enterococcal isolates from 99 healthy humans in
Portugal
Basis of
isolate
selection
Samples resistant
to the antibiotics
used in selection
% Co-resistance to
other antibioticsb,c,d
No. of resistant
isolates of each
species selected in
the different plates
Non-susceptibilitya to
VA
MIC
‡8
mg ⁄L
TEC
MIC
‡8
mg ⁄L
AMP
MIC
‡16
mg ⁄L
TE
MIC
‡8
mg ⁄L
E
MIC
‡1
mg ⁄L
CIP
MIC
‡2
mg ⁄L
C
MIC
‡16
mg ⁄L
GM
MIC
‡500
mg ⁄L
STR
MIC
‡2000
mg ⁄L
KAN
MIC
‡2000
mg ⁄L
NITe
MIC
‡64
mg ⁄L
Q ⁄Db,e
MIC
‡2
mg ⁄L
No antibiotic TE 55; E 67; E. faecalis (n = 52) 0 ⁄ 52 0 ⁄ 52 0 ⁄ 52 25 ⁄ 52 16 ⁄ 52 17 ⁄ 52 11 ⁄ 52 1 ⁄ 52 9 ⁄ 52 5 ⁄ 52 0 ⁄ 52 27 ⁄ 27
CIP 53; C 22; E. faecium (n = 53) 0 ⁄ 53 0 ⁄ 53 0 ⁄ 53 18 ⁄ 53 34 ⁄ 53 27 ⁄ 53 5 ⁄ 53 1 ⁄ 53 12 ⁄ 53 8 ⁄ 53 5 ⁄ 53 23 ⁄ 29
GM 3; STR 30; Enterococcus spp. (n = 14) 0 ⁄ 14 0 ⁄ 14 0 ⁄ 14 3 ⁄ 14 4 ⁄ 14 4 ⁄ 14 2 ⁄ 14 0 ⁄ 14 4 ⁄ 14 1 ⁄ 14 3 ⁄ 14 5 ⁄ 5
KAN 20; NIT 41;
Q ⁄D 91
0 ⁄ 119 0 ⁄ 119 0 ⁄ 119 46 ⁄ 119 54 ⁄ 119 48 ⁄ 119 18 ⁄ 119 2 ⁄ 119 25 ⁄ 119 14 ⁄ 119 8 ⁄ 119 55 ⁄ 61
Vancomycin
(6 mg ⁄L)
5 TEC 67; AMP 33; E. faecium (n = 4) 4 ⁄ 4b 4 ⁄ 4 2 ⁄ 4 4 ⁄ 4 4 ⁄ 4 3 ⁄ 4 2 ⁄ 4 2 ⁄ 4 2 ⁄ 4 2 ⁄ 4 2 ⁄ 4 3/4
TE 67; E 83; E. gallinarum (n = 2) 2 ⁄ 2c 0 ⁄ 2 0 ⁄ 2 0 ⁄ 2 1 ⁄ 2 2 ⁄ 2 0 ⁄ 2 0 ⁄ 2 0 ⁄ 2 0 ⁄ 2 0 ⁄ 2 1 ⁄ 2
CIP 67; C 33;
GM 33; STR 33;
KAN 33; Q ⁄D 50
6 ⁄ 6 4 ⁄ 6 2 ⁄ 6 4 ⁄ 6 3 ⁄ 6 5 ⁄ 6 2 ⁄ 6 2 ⁄ 6 2 ⁄ 6 2 ⁄ 6 2 ⁄ 6 4 ⁄ 6
Gentamicin
(125 mg ⁄L)
11 VA 18; TEC 9; E. faecalis (n = 6) 0 ⁄ 6 0 ⁄ 6 0 ⁄ 6 6 ⁄ 6 4 ⁄ 6 3 ⁄ 6 3 ⁄ 6 6 ⁄ 6 5 ⁄ 6 6 ⁄ 6 0 ⁄ 6 4 ⁄ 4
AMP 18; TE 100; E. faecium (n = 3) 2 ⁄ 3 1 ⁄ 3 2 ⁄ 3 3 ⁄ 3 3 ⁄ 3 3 ⁄ 3 2 ⁄ 3 3 ⁄ 3 2 ⁄ 3 3 ⁄ 3 3 ⁄ 3 1 ⁄ 1
E 91; CIP 64; E. gallinarum (n = 1) 1 ⁄ 1 0 ⁄ 1 0 ⁄ 1 1 ⁄ 1 1 ⁄ 1 1 ⁄ 1 1 ⁄ 1 1 ⁄ 1 0 ⁄ 1 1 ⁄ 1 1 ⁄ 1 ND
C 64; STR 73; Enterococcus spp. (n = 3) 0 ⁄ 3 0 ⁄ 3 0 ⁄ 3 2 ⁄ 3 3 ⁄ 3 1 ⁄ 3 1 ⁄ 3 3 ⁄ 3 2 ⁄ 3 3 ⁄ 3 0 ⁄ 3 1 ⁄ 1
KAN 100;
Q ⁄D 100
2 ⁄ 13 1 ⁄ 13 2 ⁄ 13 12 ⁄ 13 11 ⁄ 13 8 ⁄ 13 7 ⁄ 13 13 ⁄ 13 9 ⁄ 13 13 ⁄ 13 4 ⁄ 13 6 ⁄ 6
Streptomycin
(1000 mg ⁄L)
52 TE 89; E 89; E. faecalis (n = 41) 0 ⁄ 41 0 ⁄ 41 0 ⁄ 41 38 ⁄ 41 36 ⁄ 41 20 ⁄ 41 22 ⁄ 41 0 ⁄ 41 41 ⁄ 41 26 ⁄ 41 2 ⁄ 41 18 ⁄ 18
CIP 29; C 48; E. faecium (n = 18) 0 ⁄ 18 0 ⁄ 18 1 ⁄ 18 13 ⁄ 18 17 ⁄ 18 13 ⁄ 18 3 ⁄ 18 0 ⁄ 18 18 ⁄ 18 5 ⁄ 18 9 ⁄ 17 6 ⁄ 6
KAN 59; Q ⁄D 95; Enterococcus spp. (n = 6) 0 ⁄ 6 0 ⁄ 6 0 ⁄ 6 3 ⁄ 6 4 ⁄ 6 3 ⁄ 6 2 ⁄ 6 0 ⁄ 6 6 ⁄ 6 2 ⁄ 6 0 ⁄ 6 ND
NIT 5
0 ⁄ 65 0 ⁄ 65 1 ⁄ 65 54 ⁄ 65 57 ⁄ 65 36 ⁄ 65 27 ⁄ 65 0 ⁄ 65 65 ⁄ 65 33 ⁄ 65 11 ⁄ 64 24 ⁄ 24
Kanamycin
(500 mg ⁄L)
40 TE 85; E 77; E. faecalis (n = 25) 0 ⁄ 25 0 ⁄ 25 0 ⁄ 25 24 ⁄ 25 22 ⁄ 25 8 ⁄ 25 13 ⁄ 25 0 ⁄ 25 23 ⁄ 25 25 ⁄ 25 1 ⁄ 24 15 ⁄ 15
CIP 56; C 33; E. faecium (n = 18) 0 ⁄ 18 0 ⁄ 18 0 ⁄ 18 11 ⁄ 18 12 ⁄ 18 16 ⁄ 18 3 ⁄ 18 0 ⁄ 18 6 ⁄ 18 18 ⁄ 18 10 ⁄ 17 4 ⁄ 4
STR 72; Enterococcus spp. (n = 1) 0 ⁄ 1 0 ⁄ 1 0 ⁄ 1 1 ⁄ 1 0 ⁄ 1 0 ⁄ 1 0 ⁄ 1 0 ⁄ 1 1 ⁄ 1 1 ⁄ 1 0 ⁄ 1 ND
Q ⁄D 100
0 ⁄ 44 0 ⁄ 44 0 ⁄ 44 36 ⁄ 44 34 ⁄ 44 24 ⁄ 44 16 ⁄ 44 0 ⁄ 44 30 ⁄ 44 44 ⁄ 44 11 ⁄ 42 19 ⁄ 19
Total n = 247
VA, vancomycin; TEC, teicoplanin; AMP, ampicillin; TE, tetracycline; E, erythromycin; CIP, ciproﬂoxacin; C, chloramphenicol; GM, high-level resistance to gentamicin; STR,
high-level resistance to streptomycin; KAN, high level resistance to kanamycin; Q ⁄D, quinupristin–dalfopristin; NIT, nitrofurantoin; ND, not determined.
aResistant and intermediately-resistant enterococci were considered together; bE. faecalis is inherently resistant to Q ⁄D; call vancomycin-resistant E. faecium isolates contained
vanA; dall vancomycin-resistant E. gallinarum isolates contained vanC1; etechnical issues impaired the study of nitrofurantoin and quinupristin–dalfopristin susceptibility for
all isolates.
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clonal spread via the food chain, as has been
suggested previously [4,19]. The presence in two
HH vancomycin-resistant isolates of purK-6 and
Tn1546 type D, associated with enterococci of
animal origin, further supports this hypothesis
[5,15]. Notably, Tn1546 type PP-5 and purK-1,
linked to strains from hospitalised patients
[5,6,16,17], were found in an HH with no antibi-
otic or hospital exposure. The absence of common
resistance genes in some isolates resistant to
kanamycin, erythromycin or quinupristin–dal-
fopristin suggests that other unknown resistance
mechanisms may exist in the community.
In summary, healthy Portuguese individuals
are frequently colonised with ABRE. Selection of
these strains by factors other than antibiotics,
and ⁄ or possible strain ⁄ gene transmission from
animal sources, might increase the human reser-
voir of clinically relevant ABRE outside of the
hospital setting.
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